A detailed history of First Trust Advisors LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 107,674 shares of GH stock, worth $3.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107,674
Holding current value
$3.95 Million
% of portfolio
0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$22.3 - $36.29 $2.4 Million - $3.91 Million
107,674 New
107,674 $2.47 Million
Q3 2023

Nov 13, 2023

BUY
$25.8 - $39.97 $2.06 Million - $3.19 Million
79,916 New
79,916 $2.37 Million
Q4 2022

Feb 09, 2023

BUY
$25.44 - $59.78 $3.13 Million - $7.35 Million
122,947 New
122,947 $3.34 Million
Q2 2022

Aug 12, 2022

SELL
$28.82 - $77.35 $702,977 - $1.89 Million
-24,392 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$48.25 - $100.49 $765,872 - $1.6 Million
15,873 Added 186.32%
24,392 $1.62 Million
Q4 2021

Feb 08, 2022

SELL
$88.71 - $120.43 $926,575 - $1.26 Million
-10,445 Reduced 55.08%
8,519 $852,000
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $20.4 Million - $27.4 Million
-207,040 Reduced 91.61%
18,964 $2.37 Million
Q2 2021

Aug 16, 2021

SELL
$109.77 - $165.68 $6.87 Million - $10.4 Million
-62,565 Reduced 21.68%
226,004 $28.1 Million
Q1 2021

May 14, 2021

SELL
$127.04 - $179.1 $5.32 Million - $7.5 Million
-41,877 Reduced 12.67%
288,569 $44.1 Million
Q4 2020

Feb 02, 2021

BUY
$99.96 - $135.93 $24.7 Million - $33.6 Million
247,291 Added 297.39%
330,446 $42.6 Million
Q3 2020

Nov 05, 2020

SELL
$80.32 - $111.8 $18.6 Million - $25.9 Million
-231,369 Reduced 73.56%
83,155 $9.3 Million
Q2 2020

Jul 22, 2020

SELL
$60.49 - $97.5 $94,001 - $151,515
-1,554 Reduced 0.49%
314,524 $25.5 Million
Q1 2020

May 06, 2020

BUY
$59.04 - $88.81 $18.7 Million - $28.1 Million
316,078 New
316,078 $22 Million
Q4 2019

Feb 03, 2020

SELL
$59.49 - $82.78 $4.77 Million - $6.64 Million
-80,251 Closed
0 $0
Q3 2019

Nov 04, 2019

BUY
$62.59 - $110.3 $441,760 - $778,497
7,058 Added 9.64%
80,251 $5.12 Million
Q2 2019

Jul 30, 2019

BUY
$63.94 - $91.11 $84,528 - $120,447
1,322 Added 1.84%
73,193 $6.32 Million
Q1 2019

May 09, 2019

BUY
$34.3 - $97.98 $9,055 - $25,866
264 Added 0.37%
71,871 $5.51 Million
Q4 2018

Feb 07, 2019

BUY
$29.2 - $46.1 $2.09 Million - $3.3 Million
71,607 New
71,607 $2.69 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.75B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.